Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ken-Ichi Kozaki is active.

Publication


Featured researches published by Ken-Ichi Kozaki.


Cancer Research | 2015

MiR-634 activates the mitochondrial apoptosis pathway and enhances chemotherapy-induced cytotoxicity

Naoto Fujiwara; Jun Inoue; Tatsuyuki Kawano; Kousuke Tanimoto; Ken-Ichi Kozaki; Johji Inazawa

Some tumor-suppressing miRNAs target multiple oncogenes concurrently and therefore may be useful as cancer therapeutic agents. Further, such miRNAs may be useful to address chemotherapeutic resistance in cancer, which remains a primary clinical challenge in need of solutions. Thus, cytoprotective processes upregulated in cancer cells that are resistant to chemotherapy are a logical target for investigation. Here, we report that overexpression of miR-634 activates the mitochondrial apoptotic pathway by direct concurrent targeting of genes associated with mitochondrial homeostasis, antiapoptosis, antioxidant ability, and autophagy. In particular, we show how enforced expression of miR-634 enhanced chemotherapy-induced cytotoxicity in a model of esophageal squamous cell carcinoma, where resistance to chemotherapy remains clinically problematic. Our findings illustrate how reversing miR-634-mediated cytoprotective processes may offer a broadly useful approach to improving cancer therapy.


PLOS ONE | 2016

A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516

Kazuya Arai; Takanori Eguchi; M. Mamunur Rahman; Ruriko Sakamoto; Norio Masuda; Tetsuya Nakatsura; Stuart K. Calderwood; Ken-Ichi Kozaki; Manabu Itoh

Epithelial-mesenchymal transition (EMT) is a crucial pathological event in cancer, particularly in tumor cell budding and metastasis. Therefore, control of EMT can represent a novel therapeutic strategy in cancer. Here, we introduce an innovative three-dimensional (3D) high-throughput screening (HTS) system that leads to an identification of EMT inhibitors. For the establishment of the novel 3D-HTS system, we chose NanoCulture Plates (NCP) that provided a gel-free micro-patterned scaffold for cells and were independent of other spheroid formation systems using soft-agar. In the NCP-based 3D cell culture system, A549 lung cancer cells migrated, gathered, and then formed multiple spheroids within 7 days. Live cell imaging experiments showed that an established EMT-inducer TGF-β promoted peripheral cells around the core of spheroids to acquire mesenchymal spindle shapes, loss of intercellular adhesion, and migration from the spheroids. Along with such morphological change, EMT-related gene expression signatures were altered, particularly alteration of mRNA levels of ECAD/CDH1, NCAD/CDH2, VIM and ZEB1/TCF8. These EMT-related phenotypic changes were blocked by SB431542, a TGF-βreceptor I (TGFβR1) inhibitor. Inside of the spheroids were highly hypoxic; in contrast, spheroid-derived peripheral migrating cells were normoxic, revealed by visualization and quantification using Hypoxia Probe. Thus, TGF-β-triggered EMT caused spheroid hypoplasia and loss of hypoxia. Spheroid EMT inhibitory (SEMTIN) activity of SB431542 was calculated from fluorescence intensities of the Hypoxia Probe, and then was utilized in a drug screening of EMT-inhibitory small molecule compounds. In a pilot screening, 9 of 1,330 compounds were above the thresholds of the SEMTIN activity and cell viability. Finally, two compounds SB-525334 and SU9516 showed SEMTIN activities in a dose dependent manner. SB-525334 was a known TGFβR1 inhibitor. SU9516 was a cyclin-dependent kinase 2 (CDK2) inhibitor, which we showed also had an EMT-inhibitory activity. The half maximal inhibitory concentration (IC50) of SB-525334 and SU9516 were 0.31 μM and 1.21 μM, respectively, while IC50 of SB431542 was 2.38 μM. Taken together, it was shown that this 3D NCP-based HTS system was useful for screening of EMT-regulatory drugs.


Journal of Cellular Biochemistry | 2017

Intracellular MMP3 promotes HSP gene expression in collaboration with chromobox proteins.

Takanori Eguchi; Stuart K. Calderwood; Masaharu Takigawa; Satoshi Kubota; Ken-Ichi Kozaki

Matrix metalloproteinases (MMPs) are crucial factors in tumor progression, inflammatory/immune responses and tissue development/regeneration. Of note, it has been known that MMPs promote genome instability, epithelial‐mesenchymal transition, invasion, and metastasis in tumor progression. We previously reported that human MMP3 could translocate into cellular nuclei and control transcription in human chondrosarcoma‐derived cells and in articular cartilage (Eguchi et al. [2008] Mol Cell Biol 28(7):2391–2413); however, further transcriptional target genes and cofactors of intranuclear MMP3 have not been uncovered. In this paper, we used transcriptomics analysis in order to examine novel transcriptional target genes regulated by intracellular MMP3. We found that mRNA levels of HSP family members (HSP70B′, HSP72, HSP40/DNAJ, and HSP20/CRYAB) are upregulated by the intracellular MMP3 overload. Bioinformatic analysis predicted several transcription factors that possibly interact with MMP3. Among these factors, heat shock factor 1 (HSF1) cooperated with the MMP3 to activate the HSP70B′ gene promoter in reporter gene assays, while a dominant negative HSF1 blocked the role for MMP3 in the trans‐activation. The hemopexin‐like repeat (PEX) domain of the human MMP3 was essential for transcriptional induction of the HSP70B′ gene. In addition, chromobox proteins CBX5/HP1α and CBX3/HP1γ cooperated with the PEX domain in induction of HSP70B′ mRNA. Taken together, this study newly clarified that intracellular MMP3 cooperate with CBXs/HP1s in transcriptional promotion of HSP genes. J. Cell. Biochem. 118: 43–51, 2017.


PLOS ONE | 2018

Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment

Takanori Eguchi; Chiharu Sogawa; Yuka Okusha; Kenta Uchibe; Ryosuke Iinuma; Kisho Ono; Keisuke Nakano; Jun Murakami; Manabu Itoh; Kazuya Arai; Toshifumi Fujiwara; Yuri Namba; Yoshiki Murata; Kazumi Ohyama; Manami Shimomura; Hirohiko Okamura; Masaharu Takigawa; Tetsuya Nakatsura; Ken-Ichi Kozaki; Kuniaki Okamoto; Stuart K. Calderwood

Ability to form cellular aggregations such as tumorspheres and spheroids have been used as a morphological marker of malignant cancer cells and in particular cancer stem cells (CSC). However, the common definition of the types of cellular aggregation formed by cancer cells has not been available. We examined morphologies of 67 cell lines cultured on three dimensional morphology enhancing NanoCulture Plates (NCP) and classified the types of cellular aggregates that form. Among the 67 cell lines, 49 cell lines formed spheres or spheroids, 8 cell lines formed grape-like aggregation (GLA), 8 cell lines formed other types of aggregation, and 3 cell lines formed monolayer sheets. Seven GLA-forming cell lines were derived from adenocarcinoma among the 8 lines. A neuroendocrine adenocarcinoma cell line PC-3 formed asymmetric GLA with ductal structures on the NCPs and rapidly growing asymmetric tumors that metastasized to lymph nodes in immunocompromised mice. In contrast, another adenocarcinoma cell line DU-145 formed spheroids in vitro and spheroid-like tumors in vivo that did not metastasize to lymph nodes until day 50 after transplantation. Culture in the 3D nanoenvironment and in a defined stem cell medium enabled the neuroendocrine adenocarcinoma cells to form slowly growing large organoids that expressed multiple stem cell markers, neuroendocrine markers, intercellular adhesion molecules, and oncogenes in vitro. In contrast, the more commonly used 2D serum-contained environment reduced intercellular adhesion and induced mesenchymal transition and promoted rapid growth of the cells. In addition, the 3D stemness nanoenvironment promoted secretion of HSP90 and EpCAM-exosomes, a marker of CSC phenotype, from the neuroendocrine organoids. These findings indicate that the NCP-based 3D environment enables cells to form stem cell tumoroids with multipotency and model more accurately the in vivo tumor status at the levels of morphology and gene expression.


Biochemical and Biophysical Research Communications | 2018

Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition

Toshifumi Fujiwara; Takanori Eguchi; Chiharu Sogawa; Kisho Ono; Jun Murakami; Soichiro Ibaragi; Junichi Asaumi; Kuniaki Okamoto; Stuart K. Calderwood; Ken-Ichi Kozaki

Genetic amplification, overexpression, and increased signaling from the epidermal growth factor receptor (EGFR) are often found in oral squamous cell carcinoma (OSCC) and thus EGFR is frequently targeted molecularly by the therapeutic antibody cetuximab. We assessed effects of cetuximab in control of EGF-driven malignant traits of OSCC cells. EGF stimulation promoted progression level of mesenchymal traits in OSCC cells, which were attenuated by cetuximab but incompletely. We pursued a potential mechanism underlying such incomplete attenuation of OSCC malignant traits. Cetuximab promoted secretion of EGFR-EVs by OSCC cells and failed to inhibit EGF-driven secretion of EGFR-EVs. Cetuximab was also found to be robustly secreted with the EGFR-EVs by the OSCC cells. Thus, EGF promotes the level of mesenchymal traits of OSCC cells and secretion of EGFR-EVs, which involve cetuximab resistance.


Journal of Cellular Biochemistry | 2018

The intranuclear PEX domain of MMP involves proliferation, migration, and metastasis of aggressive adenocarcinoma cells

Yuka Okusha; Takanori Eguchi; Chiharu Sogawa; Tatsuo Okui; Keisuke Nakano; Kuniaki Okamoto; Ken-Ichi Kozaki

Members of matrix metalloproteinase (MMP) family promote cancer cell migration, invasion, and metastasis through alteration of the tumor milieu, intracellular signaling pathways, and transcription. We examined gene expression signatures of colon adenocarcinoma cell lines with different metastatic potentials and found that rapidly metastatic cells powerfully expressed genes encoding MMP3 and MMP9. The non‐proteolytic PEX isoform and proteolytic isoforms of MMPs were significantly expressed in the metastatic cells in vitro. Knockdown of MMP3 attenuated cancer cell migration and invasion in vitro and lung metastasis in vivo. Profound nuclear localization of MMP3/PEX was found in tumor‐stroma marginal area. In contrast, MMP9 was localized in central area of subcutaneous tumors. Overexpression of the PEX isoform of MMP3 promoted proliferation and migration of the rapidly metastatic cells in vitro. Taken together, the non‐proteolytic PEX isoform of MMPs locating in cell nuclei involves proliferation, migration, and subsequent metastasis of aggressive adenocarcinoma cells.


Cancer Research | 2015

Abstract 2278: The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma

Tomoki Muramatsu; Ken-Ichi Kozaki; Seiya Imoto; Rui Yamaguchi; Hitoshi Tsuda; Tatsuyuki Kawano; Maki Morishita; Satoru Miyano; Johji Inazawa

Metastasis is one of the critical factors contributing to poor prognosis in cancer, but the mechanisms are poorly understood. We established a highly metastatic subline (HOC313-LM) derived from an oral squamous cell carcinoma cell line (HOC313) for uncovering the metastatic mechanisms. We identified deoxyhypusine synthase (DHPS) as a metastasis-related gene through the specific amplification at 19p13.2-p13.13 in the HOC313-LM. Overexpression of DHPS promoted cell motility, invasion and metastasis through activation of the RhoA signaling pathway, and increased the tumor formation in vivo. We also demonstrated that eukaryotic translation factor 5A (eIF5A) bound to RhoA mRNA and regulated its translation. Moreover, GC7, a DHPS inhibitor, showed significant decrease in the tumor formation in vivo. In patients with esophageal squamous cell carcinoma (ESCC), overexpression of DHPS in ESCC tumors was significantly associated with worse recurrence-free survival, and correlated with distant metastasis. Our elucidation of these molecular mechanisms within the hypusine cascade suggests opportunities for novel therapeutic targets in SCC. Citation Format: Tomoki Muramatsu, Ken-ichi Kozaki, Seiya Imoto, Rui Yamaguchi, Hitoshi Tsuda, Tatsuyuki Kawano, Maki Morishita, Satoru Miyano, Johji Inazawa. The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2278. doi:10.1158/1538-7445.AM2015-2278


Journal of Hard Tissue Biology | 2016

Changes in Metallothionein Isoform Expression in the Bones of Ovariectomized Rats

Chiharu Sogawa; Mika Ikegame; Ikuko Miyazaki; Toshiaki Ara; Yasuhiro Imamura; Yuka Okusha; Kazumi Ohyama; Masato Asanuma; Norio Sogawa; Toshio Yamamoto; Ken-Ichi Kozaki


Archive | 2014

マイクロrnaの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物

Johji Inazawa; 稲澤 譲治; Jun Inoue; 井上 純; Shinsuke Yamamoto; 信祐 山本; Tatsuyuki Kawano; 辰幸 河野; Ken-Ichi Kozaki; 健一 小崎


Archive | 2011

HECT-typeUbiquitinLigaseITCHTargetsLysosomal-associated Protein Multispanning Transmembrane 5 (LAPTM5) and

Takaya Ishihara; Jun Inoue; Ken-Ichi Kozaki; Issei Imoto; Johji Inazawa

Collaboration


Dive into the Ken-Ichi Kozaki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Stuart K. Calderwood

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Issei Imoto

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tatsuyuki Kawano

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge